Parnell Pharmaceuticals Holdings Current Ratio 2014-2018 | PARNF
Parnell Pharmaceuticals Holdings current ratio from 2014 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Parnell Pharmaceuticals Holdings Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2018-06-30 |
$0.01B |
$0.01B |
0.82 |
| 2018-03-31 |
$0.01B |
$0.01B |
0.69 |
| 2017-12-31 |
$0.01B |
$0.01B |
0.84 |
| 2016-12-31 |
$0.01B |
$0.01B |
1.89 |
| 2016-09-30 |
$0.01B |
$0.01B |
0.61 |
| 2015-12-31 |
$0.01B |
$0.01B |
1.63 |
| 2015-09-30 |
$0.00B |
|
0.00 |
| 2015-06-30 |
$0.02B |
$0.01B |
3.53 |
| 2015-03-31 |
$0.00B |
|
0.00 |
| 2014-12-31 |
$0.02B |
$0.01B |
1.76 |
| 2014-09-30 |
$0.00B |
|
0.00 |
| 2014-06-30 |
$0.03B |
$0.01B |
2.59 |
| 2014-03-31 |
$0.01B |
$0.01B |
1.05 |
| 2013-06-30 |
$0.01B |
$0.02B |
0.35 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
|
